MBRX ▼ -1.8% - Moleculin Biotech, Inc.
$MBRX - Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
29-SEP-2026 08:45 AM ET
Share this post
More filings for $MBRX
MBRX ▼ -1.7% - Moleculin Biotech, Inc.Sep 28, 2026MBRX ▲ +14.5% - Moleculin Biotech, Inc.Sep 25, 2026MBRX ▲ +4.2% - Moleculin Biotech, Inc.Sep 14, 2026MBRX ▼ -2.4% - Moleculin Biotech, Inc.Sep 11, 2026MBRX - Moleculin Biotech, Inc. - SEC Filing Update (25-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 25, 2026MBRX - Moleculin Biotech, Inc. - SEC Filing Update (25-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 25, 2026
View full $MBRX filing history →💬 Comments
Loading comments…
Leave a comment